These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods. Skowronek J, Piotrowski T. Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593 [Abstract] [Full Text] [Related]
4. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV. Cancer; 2004 Aug 01; 101(3):508-17. PubMed ID: 15274063 [Abstract] [Full Text] [Related]
5. Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice. Dragun AE, Huang B, Tucker TC, Spanos WJ. Breast J; 2012 Aug 01; 18(4):318-25. PubMed ID: 22607016 [Abstract] [Full Text] [Related]
6. Local recurrence patterns in breast cancer patients treated with oncoplastic reduction mammaplasty and radiotherapy. Eaton BR, Losken A, Okwan-Duodu D, Schuster DM, Switchenko JM, Mister D, Godette K, Torres MA. Ann Surg Oncol; 2014 Jan 01; 21(1):93-9. PubMed ID: 24081796 [Abstract] [Full Text] [Related]
7. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M. Breast Cancer Res Treat; 2008 Jun 01; 109(3):405-16. PubMed ID: 17687650 [Abstract] [Full Text] [Related]
8. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ. Cancer; 2005 Jun 15; 103(12):2447-54. PubMed ID: 15887223 [Abstract] [Full Text] [Related]
9. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study. Sanpaolo P, Barbieri V, Genovesi D. Eur J Surg Oncol; 2011 Oct 15; 37(10):876-82. PubMed ID: 21824742 [Abstract] [Full Text] [Related]
10. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer. Cefaro GA, Genovesi D, Trignani M, DI Nicola M. Anticancer Res; 2014 Mar 15; 34(3):1207-12. PubMed ID: 24596361 [Abstract] [Full Text] [Related]
11. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. Hudis CA, Barlow WE, Costantino JP, Gray RJ, Pritchard KI, Chapman JA, Sparano JA, Hunsberger S, Enos RA, Gelber RD, Zujewski JA. J Clin Oncol; 2007 May 20; 25(15):2127-32. PubMed ID: 17513820 [Abstract] [Full Text] [Related]
12. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H. Cancer; 2006 Jan 01; 106(1):35-41. PubMed ID: 16333848 [Abstract] [Full Text] [Related]
13. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA. Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):e145-52. PubMed ID: 21605948 [Abstract] [Full Text] [Related]
14. Breast cancer recurrences in elderly patients after lumpectomy. Shah S, Doyle K, Lange EM, Shen P, Pennell T, Ferree C, Levine EA, Perrier ND. Am Surg; 2002 Aug 01; 68(8):735-9. PubMed ID: 12206612 [Abstract] [Full Text] [Related]
15. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results]. Fodor J, Mózsa E, Zaka Z, Polgár C, Major T. Magy Onkol; 2005 Aug 01; 49(3):203, 205-8. PubMed ID: 16249814 [Abstract] [Full Text] [Related]
16. Mortality impact of less-than-standard therapy in older breast cancer patients. Yood MU, Owusu C, Buist DS, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA. J Am Coll Surg; 2008 Jan 01; 206(1):66-75. PubMed ID: 18155570 [Abstract] [Full Text] [Related]
17. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Jain D. Am J Clin Oncol; 2013 Aug 01; 36(4):375-80. PubMed ID: 22643566 [Abstract] [Full Text] [Related]
18. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period. Fortunato L, Mascaro A, Poccia I, Andrich R, Amini M, Costarelli L, Cortese G, Farina M, Vitelli C. Ann Surg Oncol; 2012 Apr 01; 19(4):1107-14. PubMed ID: 21913022 [Abstract] [Full Text] [Related]
19. Factors predicting in-breast tumor recurrence after breast-conserving surgery. Mechera R, Viehl CT, Oertli D. Breast Cancer Res Treat; 2009 Jul 01; 116(1):171-7. PubMed ID: 18815880 [Abstract] [Full Text] [Related]